Search results
Results from the WOW.Com Content Network
The National Health and Medical Research Council (NHMRC) is the main statutory authority of the Australian Government responsible for medical research. It was the eighth largest research funding body in the world in 2016, [ 1 ] and NHMRC-funded research is globally recognised for its high quality. [ 2 ]
Some grants are specified for "new investigators", which is defined as someone who has not received a prior NIH grant other than a career award or specific small grants (R15, R21, R56, etc.). An "early stage investigator" is someone who has received their PhD or MD or has finished residency within the past 10 years. [5]
In drug development and medical device development [1] the Investigator's Brochure (IB) is a comprehensive document summarizing the body of information about an investigational product ("IP" or "study drug") obtained during a drug trial. The IB is a document of critical importance throughout the drug development process and is updated with new ...
Grant management software is a program or application that helps non-profits administer the grant process. Some software is designed to help foundations (known as "grantmakers") to organize, prioritize, and process the grant applications they receive from charities (known as "grantseekers"), as well as simplify oversight of the grants they make.
Challenge grants are funds disbursed by one party (the grant maker), usually a government agency, corporation, foundation or trust (sometimes anonymously), typically to a non-profit entity or educational institution (the grantee) upon completion of the challenge requirement(s).
In many countries, the term principal investigator (PI) refers to the holder of an independent grant and the lead researcher for the grant project, usually in the sciences, such as a laboratory study or a clinical trial. The phrase is also often used as a synonym for "head of the laboratory" or "research group leader".
The main product of the CONSORT Group is the CONSORT Statement, [1] which is an evidence-based, minimum set of recommendations for reporting randomized trials.It offers a standard way for authors to prepare reports of trial findings, facilitating their complete and transparent reporting, reducing the influence of bias on their results, and aiding their critical appraisal and interpretation.
Supports and conducts research, both basic and clinical, on the normal and diseased nervous system, fosters the training of investigators in the basic and clinical neurosciences, and seeks better understanding, diagnosis, treatment, and prevention of neurological disorders. 1950 $1,656.3 ninds.nih.gov: National Library of Medicine: NLM